Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
2018 · Nature Communications · 87 citations
https://doi.org/10.1038/s41467-018-06954-z
S
Songguang Ju
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
1.3K
Citations
16
h-index
24
i10-index
Songguang Ju is an academic researcher. The author has contributed to research in topics: Immunotherapy and Immune Responses & T-cell and B-cell Immunology & CAR-T cell therapy research. The author has an h-index of 16, co-authored 40 publications.
ORCID: 0000-0001-9213-728XPapers by this author
worksGadd45b and Gadd45g are important for anti‐tumor immune responses
2009 · European Journal of Immunology · 74 citations
https://doi.org/10.1002/eji.200839154
CD13<sup>+</sup>CD4<sup>+</sup>CD25<sup>hi</sup>regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients
2009 · Cell Cycle · 32 citations
https://doi.org/10.4161/cc.8.16.9302
Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment
2023 · Translational Oncology · 9 citations
https://doi.org/10.1016/j.tranon.2023.101856
An Anti-Human CD13 Monoclonal Antibody That Suppresses the Suppressive Function of Treg Cells
2013 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 4 citations
https://doi.org/10.1089/mab.2012.0078
Oncolytic vaccinia virus armed with 4–1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model
2024 · Translational Oncology · 2 citations
https://doi.org/10.1016/j.tranon.2024.102151
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat